RIBOZYME AND OMICS
Seong-wook Lee, CEO of Rznomics inc., will participate in the KSMO 2024 Korean Oncology Society, which will be held on Thursday, September 26, 2024, to make a presentation on the topic below.
For more information, please refer to the information and link below.
- Name of event: KSMO 2024 Korean Society of Oncology
- Date and time: September 26, 2024 (Thu) 14:10 to 15:40
- Topic : Anti-cancer RNA editing therapy based on telomerase reverse transcriptase (TERT) mRNA-splicing ribozyme
- link : KSMO 2024 (ksmoconference.org)
- Venue: COEX, Seoul